Trimethyl-[4-(4-methyl-2-oxo-pyrrolidin-1-yl)-but-2-ynyl]-ammonium iodide

ID: ALA119508

Chembl Id: CHEMBL119508

PubChem CID: 14964512

Max Phase: Preclinical

Molecular Formula: C12H21IN2O

Molecular Weight: 209.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H]1CC(=O)N(CC#CC[N+](C)(C)C)C1.[I-]

Standard InChI:  InChI=1S/C12H21N2O.HI/c1-11-9-12(15)13(10-11)7-5-6-8-14(2,3)4;/h11H,7-10H2,1-4H3;1H/q+1;/p-1/t11-;/m1./s1

Standard InChI Key:  LWCMIKHZQAGDAM-RFVHGSKJSA-M

Associated Targets(non-human)

Chrm2 Muscarinic acetylcholine receptor M2 (1011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm1 Muscarinic acetylcholine receptor M1 (3437 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm1 Muscarinic receptor M1 and M2 (189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 209.31Molecular Weight (Monoisotopic): 209.1648AlogP: 0.56#Rotatable Bonds: 2
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 1HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: -3.66CX LogD: -3.66
Aromatic Rings: Heavy Atoms: 15QED Weighted: 0.48Np Likeness Score: 0.07

References

1. Trybulski EJ, Zhang J, Kramss RH, Mangano RM..  (1993)  The synthesis and biochemical pharmacology of enantiomerically pure methylated oxotremorine derivatives.,  36  (23): [PMID:8246221] [10.1021/jm00075a007]

Source